Company intelligence / Profile preview
Guangzhou Bio-gene Technology Co., Ltd.
Guangzhou, Guangdong Province, 中国（China）gzbiogene.com ↗
- Ownership
- Private
- Employees
- ~4
- Development stage
- Phase 2
01
Overview
Guangzhou Bio-gene has advanced one autologous CAR-T candidate into formal Phase 1 clinical trials, with six additional autologous and two allogenic candidates in investigator-led studies. The lead program BG1805 targets CLL1 for relapsed/refractory AML and has shown promising efficacy in early-stage studies. Other pipeline assets target major antigens such as CD19, CD22, BCMA, and CD7 across various blood cancers. The company collaborates with top Chinese hospitals to demonstrate safety and efficacy of its next-generation CAR-T therapies.
- Therapeutic areas
- OncologyImmunologyHematology
- Modalities
- Autologous CAR-T cell therapyAllogeneic (universal) CAR-T cell therapyFusion proteinsMonoclonal antibodies
- Industry
- Biotech
02
Drug pipeline
26 assets25 more assets in the full pipeline.
Request access →03
Partnerships
Collaborations with approximately twenty leading hospitals in China for clinical research/trials on their pipeline products. No major pharma partnerships publicly disclosed.
Beyond the preview
Go deeper on Guangzhou Bio-gene Technology Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guangzhou Bio-gene Technology Co., Ltd..